Assessment and treatment of neuropathic cancer pain following WHO guidelines

Pain

Volumn 79, Issue 1, 1999, Pages 15-20

  Grond, Stefan ^a   Radbruch, Lukas ^a   Meuser, Thomas ^a   Sabatowski, Rainer ^a   Loick, Georg ^a   Lehmann, Klaus A ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Anticonvulsants; Antidepressants; Corticosteroids; Neuropathic pain; NSAID; Opioids; WHO guidelines

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; CARBAMAZEPINE; CLONAZEPAM; CORTICOSTEROID; DEXAMETHASONE; DIPYRONE; FLURBIPROFEN; MORPHINE; NAPROXEN; OPIATE; TRAMADOL;

ADULT; AGED; ARTICLE; CANCER PAIN; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE BLOCK; NEURALGIA; PALLIATIVE THERAPY; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOTHERAPY; TRANSCUTANEOUS NERVE STIMULATION;

ANALGESICS; COMBINED MODALITY THERAPY; EVALUATION STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; NEURALGIA; PAIN; PROSPECTIVE STUDIES; WORLD HEALTH ORGANIZATION;

EID: 0032956752     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00138-9     Document Type: Article

References (23)

1. Arner S., Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 33:1988;11-23.
2. Ashbury A.K., Fields H.L. Pain due to peripheral nerve damage: an hypothesis. Neurology. 34:1984;1587-1590.
3. Banning A., Sjøgren P., Henriksen H. Pain causes in 200 patients referred to a multidisciplinary cancer pain clinic. Pain. 45:1991;45-48.
4. Benedetti F., Vighetti S., Amanzio M., Casadio C., Oliaro A., Bergamasco B., Maggi G. Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain. Pain. 74:1998;205-211.
5. Cherny N.I., Thaler H.T., Friedlander-Klar H., Lapin J., Foley K.M., Houde R., Portenoy R.K. Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies. Neurology. 44:1994;857-861.
6. Dellemijn P.L.I., Verbiest H.B.C., van Vliet J.J., Roos P.J., Vecht C.J. Medical therapy of malignant nerve pain. A randomised double-blind explanatory trial with naproxen versus slow-release morphine. Eur. J. Cancer. 30A:1994;1244-1250.
7. Ellemann K., Sjøgren P., Banning A.M., Jensen T.S., Smith T., Geertsen P. Trials of intravenous lidocaine on painful neuropathy in cancer patients. Clin. J. Pain. 5:1989;291-294.
8. Ferrer-Brechner, T., Treating cancer pain as a disease. In: C. Benedetti, C.R. Chapman, G. Moricca, J.J. Bonica (Eds.), Advances in Pain Research and Therapy, Vol. 7., Raven Press, New York, 1984, pp. 575-591.
9. Grond S., Zech D., Diefenbach C., Radbruch L., Lehmann K.A. Assessment of cancer pain. A prospective evaluation in 2266 cancer patients referred to a pain clinic. Pain. 64:1996;107-114.
10. Jadad A.D., Carroll D., Glynn C.J., Moore R.A., McQuay H.J. Morphine responsiveness of chronic pain: double-blind randomized crossover study with patient-controlled analgesia. Lancet. 339:1992;1367-1371.
11. Kingery W.S. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain. 73:1997;123-139.
12. Martin L.A., Hagen N.A. Neuropathic pain in cancer patients: Mechanisms, syndromes, and clinical controversies. J. Pain Symptom Manage. 14:1997;99-117.
13. McCormack K. Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain. 59:1994;9-43.
14. Portenoy R.K. Cancer pain: pathophysiology and syndromes. Lancet. 339:1992;1026-1031.
15. Sjøgren P., Banning A.M., Hebsgaard K., Petersen P., Gefke K. Intravenous lidocaine in the treatment of chronic pain caused by bone metastases. Ugeskr. Laeger. 151:1989;2144-2146.
16. Twycross, R.G., Pain relief in advanced cancer. Churchill Livingstone, Edinburgh, 1994.
17. Twycross R.G., Fairfield S. Pain in far advanced cancer. Pain. 14:1982;303-310.
18. Ventafridda V., Caraceni A. Cancer pain classification: a controversial issue (editorial). Pain. 46:1991;1-2.
19. Ventafridda V., Tamburini M., Caraceni A., De Conno F., Naldi F. A validation study of the WHO method for cancer pain relief. Cancer. 59:1987;850-856.
20. World Health Organization, Cancer pain relief, Geneva, 1986.
21. World Health Organization, Cancer pain relief, 2nd edn, with a guide to opioid availability, Geneva, 1996.
22. Yajnik S., Singh G.P., Kumar M. Phenytoin as a coanalgesic in cancer pain. J. Pain Symptom. Manage. 7:1992;209-213.
23. Zech D.F.J., Grond S., Lynch J., Hertel D., Lehmann K.A. Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain. 63:1995;65-76.